
OTV (formerly Olive Tree Ventures) is an Israel-based venture capital firm focused exclusively on digital health, investing in companies advancing telehealth, diagnostics, digital therapeutics, medical devices, and healthcare infrastructure. The firm was founded in 2015 and closed its first fund of $170 million in December 2020.
Their most common stage is seed (43% of deals). Average disclosed round size is $23.6M (across 40 rounds with reported amounts).
Portfolio
33
Fund Size
$170M
Top Stage
Seed
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
42 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Seed | $8M | Aug 2024 | |
| Series D | $42M | Jul 2024 | |
| Seed | $7.1M | Nov 2023 | |
| Series A | $33M | Aug 2023 | |
| Seed | $3M | Jan 2023 | |
| Seed | $15M | Sep 2022 | |
| Seed | $6M | Aug 2022 | |
| Seed | $2.5M | May 2022 | |
| Series C | $50M | Feb 2022 | |
| Series A | $20M | Feb 2022 | |
| JJanani | Seed | $2.2M | Jan 2022 |
| FFinless Foods | Series B | $34M | Jan 2022 |
| Seed | $2.5M | Jan 2022 | |
| Series A | $8.5M | Jan 2022 | |
| Series A | $20M | Jan 2022 | |
| JJanani.life | Seed | $2.2M | Jan 2022 |
| JJanani.life | Growth | $2.2M | Jan 2022 |
| Series B | $50M | Nov 2021 | |
| Series D | $100M | Oct 2021 | |
| LLark Technologies | Series D | $100M | Oct 2021 |
| Series D | $100M | Oct 2021 | |
| Seed | $3M | Jun 2021 | |
| Unknown | $2.9M | Jan 2021 | |
| EExcision Biotherapeutics Inc | Unknown | $60M | Jan 2021 |
| Series A | $25M | Jan 2021 |
Page 1 of 2
Top Co-Investors
Y Combinator17 shared
Soma Capital9 shared
Gaingels6 shared
Franklin Templeton5 shared
King River Capital5 shared
Deerfield4 shared
Pioneer Fund4 shared
Lightspeed Venture Partners3 shared
European Investment Bank3 shared
OurCrowd3 shared
PFM Health Sciences3 shared
Sierra Ventures3 shared
Correlation Ventures3 shared
Draper Associates3 shared
India Quotient3 shared
SteelSky Ventures2 shared
Battery Ventures2 shared
Starlight Ventures2 shared
True Ventures2 shared
Flexport2 shared
Last updated: 20 October 2026